After most cancer cells are killed, chemotherapy or radiation therapy creates aseptic inflammation due to the products of tumor cell disintegration remaining in the blood, which stimulates the NF-κB pathway to help surviving cancer cells to endure the toxicity of chemoradiotherapy. The gene discussed is NFKB1; the disease is neoplasm.